The implications are huge. Bladder cancer ranks as the sixth most common cancer in the U.S., affecting around 80,000 people ...

By Dennis Thompson HealthDay ReporterMONDAY, Aug. 18, 2025 (HealthDay News) — A new implant eliminated bladder cancer in more ...

Biomedical engineers at Duke University have developed a method to more precisely heat up gold nanoparticles to target and ...

If approved, Signatera could help physicians to monitor molecular markers of bladder cancer relapse, allowing them to ...

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.

An expert discusses how non-muscle invasive bladder cancer (NMIBC) is a localized form of urothelial cell carcinoma that primarily affects older men with smoking as the primary risk factor, requiring ...

By combining high-res imaging tools with light-absorbing nanostars, researchers can more precisely treat cancerous tumors.

An expert discusses how non-muscle invasive bladder cancer (NMIBC) creates a significant clinical and financial burden with up to 60% recurrence rates, affecting an estimated 85,000 new patients ...

Natera (NTRA) announced positive topline results from the randomized, phase III IMvigor011 clinical trial in muscle-invasive bladder cancer. The ...

Stage-4 cancer patients are living longer, challenging the idea of what it means to have and survive cancer. “The science just needs to stay a step ahead of me” ...

Before they ever crossed an ocean, Ella and Peck Filipovic had already weathered some of life’s fiercest storms.